Immatics N.V (NASDAQ: IMTX) on Tuesday, plunged -6.07% from the previous trading day, before settling in for the closing price of $5.27. Within the past 52 weeks, IMTX’s price has moved between $5.17 and $13.77.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 90.52% annually for the last half of the decade. The company achieved an average annual earnings per share of 47.21%. With a float of $88.97 million, this company’s outstanding shares have now reached $103.11 million.
In an organization with 343 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 43.41%, operating margin of -58.2%, and the pretax margin is -41.57%.
Immatics N.V (IMTX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Immatics N.V is 25.46%, while institutional ownership is 61.78%.
Immatics N.V (IMTX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -7.58% during the next five years compared to -17.16% drop over the previous five years of trading.
Immatics N.V (NASDAQ: IMTX) Trading Performance Indicators
Immatics N.V (IMTX) is currently performing well based on its current performance indicators. A quick ratio of 3.98 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.65, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.17 in one year’s time.
Technical Analysis of Immatics N.V (IMTX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.72 million. That was inferior than the volume of 1.2 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 18.54%. Additionally, its Average True Range was 0.32.
During the past 100 days, Immatics N.V’s (IMTX) raw stochastic average was set at 0.91%, which indicates a significant decrease from 7.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.11% in the past 14 days, which was higher than the 49.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.57, while its 200-day Moving Average is $9.93. However, in the short run, Immatics N.V’s stock first resistance to watch stands at $5.14. Second resistance stands at $5.33. The third major resistance level sits at $5.46. If the price goes on to break the first support level at $4.82, it is likely to go to the next support level at $4.69. The third support level lies at $4.50 if the price breaches the second support level.
Immatics N.V (NASDAQ: IMTX) Key Stats
Market capitalization of the company is 590.82 million based on 119,356K outstanding shares. Right now, sales total 58,440 K and income totals -104,980 K. The company made 55,590 K in profit during its latest quarter, and -9,420 K in sales during its previous quarter.
